Elevated Albumin to Globulin Ratio on Day 7 is Associated with Improved Function Outcomes in Acute Ischemic Stroke Patients with Intravenous Thrombolysis

References

• Xie HL, Zhang Q, Ruan GT, et al. Evaluation and validation of the prognostic value of serum albumin to globulin ratio in patients with cancer cachexia: results from a large multicenter collaboration. Front Oncol. 2021;11:707705. doi:10.3389/fonc.2021.707705
   PubMed Web of Science ®Google Scholar
• Deng Y, Pang Q, Miao RC, et al. Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma. Onco Targets Ther. 2016;9:5317–5328. doi:10.2147/OTT.S109736
   PubMed Web of Science ®Google Scholar
• Stohl W, Kenol B, Kelly AJ, Ananth Correa A, Panush RS. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheum. 2019;49:485–492. doi:10.1016/j.semarthrit.2019.05.001
   PubMed Web of Science ®Google Scholar
• Maeda S, Takeya Y, Oguro R, et al. Serum albumin/globulin ratio is associated with cognitive function in community-dwelling older people: the septuagenarians, octogenarians, nonagenarians investigation with centenarians study. Geriatr Gerontol Int. 2019;19:967–971. doi:10.1111/ggi.13751
   PubMed Web of Science ®Google Scholar
• Niedziela J, Hudzik B, Szygula-Jurkiewicz B, et al. Albumin-to-globulin ratio as an independent predictor of mortality in chronic heart failure. Biomark Med. 2018;12:749–757.
   PubMed Web of Science ®Google Scholar
• Beamer N, Coull BM, Sexton G, et al. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke. 1993;24:1133–1139. doi:10.1161/01.STR.24.8.1133
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35–41. doi:10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13:661–670. doi:10.1007/s13311-016-0483-x
   PubMed Web of Science ®Google Scholar
• McColl B, Allan S, Rothwell NJN. Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 2009;158:1049–1061. doi:10.1016/j.neuroscience.2008.08.019
   PubMed Web of Science ®Google Scholar
• Marinkovic S, Jahreis G, Wong G, Baumann H. Il-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol. 1989;142:808–812.
   PubMed Web of Science ®Google Scholar
• Jenny NS, Callas PW, Judd SE, et al. Inflammatory cytokines and ischemic stroke risk: the regards cohort. Neurology. 2019;92:e2375–e2384. doi:10.1212/WNL.0000000000007416
   PubMed Web of Science ®Google Scholar
• Coveney S, Murphy S, Belton O, et al. Inflammatory cytokines, high-sensitivity c-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack. Int J Stroke. 2021;17(2):163–171.
   PubMed Web of Science ®Google Scholar
• Xing Y, Guo ZN, Yan S, et al. Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy. Neurosci Bull. 2014;30:469–476. doi:10.1007/s12264-013-1440-x
   PubMed Web of Science ®Google Scholar
• Wnuk M, Derbisz J, Drabik L, Slowik A, Winocur E, Sarig R. C-reactive protein and white blood cell count in non-infective acute ischemic stroke patients treated with intravenous thrombolysis. J Clin Med. 2021;11:10. doi:10.3390/jcm11010010
   PubMed Web of Science ®Google Scholar
• Swarowska M, Janowska A, Polczak A, et al. The sustained increase of plasma fibrinogen during ischemic stroke predicts worse outcome independently of baseline fibrinogen level. Inflammation. 2014;37:1142–1147. doi:10.1007/s10753-014-9838-9
   PubMed Web of Science ®Google Scholar
• Shi J, Shi R, Qin W, et al. Dynamic changes in fibrinogen and prognosis of acute ischemic stroke patients treated with intravenous thrombolysis. Neurotox Res. 2020;38:775–784. doi:10.1007/s12640-020-00241-w
   PubMed Web of Science ®Google Scholar
• Qiu H, Wang M, Mi D, et al. Vitamin d status and the risk of recurrent stroke and mortality in ischemic stroke patients: data from a 24-month follow-up study in China. J Nutr Health Aging. 2017;21:766–771. doi:10.1007/s12603-016-0821-z
   PubMed Web of Science ®Google Scholar
• Cai Z-M, Wu Y-Z, Chen H-M, et al. Being at risk of malnutrition predicts poor outcomes at 3 months in acute ischemic stroke patients. Eur J Clin Nutr. 2020;74:796–805. doi:10.1038/s41430-020-0605-8
   PubMed Web of Science ®Google Scholar
• Tang H, Gong F, Guo H, et al. Malnutrition and risk of mortality in ischemic stroke patients treated with intravenous thrombolysis. Front Aging Neurosci. 2022:14:834973.
   PubMed Web of Science ®Google Scholar
• Zhang G, Pan Y, Zhang R, et al. Prevalence and prognostic significance of malnutrition risk in patients with acute ischemic stroke: results from the third China national stroke registry. Stroke. 2022;53:111–119. doi:10.1161/STROKEAHA.121.034366
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50:e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Ignacio de Ulíbarri J, González-Madroño A, NG de Villar, et al. Conut: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20:38–45.
   PubMedGoogle Scholar
• Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139:160–167. doi:10.1016/0002-9610(80)90246-9
   PubMed Web of Science ®Google Scholar
• Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82:777–783. doi:10.1093/ajcn/82.4.777
   PubMed Web of Science ®Google Scholar
• Belayev L, Pinard E, Nallet H, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke. 2002;33:1077–1084. doi:10.1161/hs0402.105555
   PubMed Web of Science ®Google Scholar
• Zoellner H, Höfler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109:2571–2580.
   PubMed Web of Science ®Google Scholar
• Halliwell BJ. Albumin–an important extracellular antioxidant? Biochem Pharmacol. 1988;37:569–571.
   PubMed Web of Science ®Google Scholar
• Tibbling G, Link H, Ohman S. Principles of albumin and igg analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977;37:385–390. doi:10.3109/00365517709091496
   PubMed Web of Science ®Google Scholar
• Makris K, Koniari K, Spanou L, et al. Prognostic significance of serum albumin level changes in acute ischemic stroke: the role of biological and analytical variation. Clin Chem Lab Med. 2016;54:143–150. doi:10.1515/cclm-2015-0281
   PubMed Web of Science ®Google Scholar
• Babu MS, Kaul S, Dadheech S, et al. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition. 2013;29:872–875. doi:10.1016/j.nut.2012.12.015
   PubMed Web of Science ®Google Scholar
• Bielewicz J, Kurzepa J, Czekajska-Chehab E, et al. Worse neurological state during acute ischemic stroke is associated with a decrease in serum albumin levels. J Mol Neurosci. 2016;58:493–496. doi:10.1007/s12031-015-0705-4
   PubMed Web of Science ®Google Scholar
• Wang C, Deng L, Qiu S, et al. Serum albumin is negatively associated with hemorrhagic transformation in acute ischemic stroke patients. Cerebrovasc Dis. 2019;47:88–94. doi:10.1159/000498855
   PubMed Web of Science ®Google Scholar
• Martin RH, Yeatts SD, Hill MD, et al. Alias (albumin in acute ischemic stroke) trials: analysis of the combined data from parts 1 and 2. Stroke. 2016;47:2355–2359. doi:10.1161/STROKEAHA.116.012825
   PubMed Web of Science ®Google Scholar
• Huang Y, Xiao Z. Albumin therapy for acute ischemic stroke: a meta-analysis. Neurol Sci. 2021;42:2713–2719. doi:10.1007/s10072-021-05244-9
   PubMed Web of Science ®Google Scholar
• Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: csppc-stroke program. Int J Stroke. 2021;16:265–272. doi:10.1177/1747493020913557
   PubMed Web of Science ®Google Scholar